A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

• Status: Completed
• Trial end date: 2020-06-03
• Target enrollment: 0
• Participant gender: All

Summary

Phase 4 clinical trial to Evaluate the blood pressure lowering effect of a Candesartan/Hydrochlorothiazide(Candemore Plus Tab) versus Candesartan/Amlodipine(Cantabell Tab) in Hypertensive Patients

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chong Kun Dang Pharmaceutical

Criteria

Inclusion Criteria:

• over 19 years old

• Agreement with written informed consent

• Hypertensive Patients

Exclusion Criteria:

• Patients with secondary hypertension

• Participated in other trial within 30 days

• In investigator's judgement